Symptom- and fraction of exhaled nitric oxide–driven strategies for asthma control: A cluster-randomized trial in primary care-Reference-Cited by-同舟云学术

Symptom- and fraction of exhaled nitric oxide–driven strategies for asthma control: A cluster-randomized trial in primary care

Published:2015-03 Issue:3 Volume:135 Page:682-688.e11
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Honkoop Persijn J.,Loijmans Rik J.B.,Termeer Evelien H.,Snoeck-Stroband Jiska B.,van den Hout Wilbert B.,Bakker Moira J.,Assendelft Willem J.J.,ter Riet Gerben,Sterk Peter J.,Schermer Tjard R.J.,Sont Jacob K.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli;Allergy,2004

2. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease;Chen;J Allergy Clin Immunol,2007

3. Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study;Siroux;Allergy,2008

4. Asthma in USA: its impact on health-related quality of life;Sullivan;J Asthma,2013

5. Annual report and accounts 2013;Asthma,2013

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of exhaled nitric oxide to guide mild asthma treatment in atopic patients and its correlation with asthma control test score: a randomized controlled trial;BMC Pulmonary Medicine;2024-08-29

2. Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma;Annals of Medicine;2024-07-25

3. Promising treatment biomarkers in asthma;Frontiers in Drug Safety and Regulation;2023-11-07

4. The treatable traits approach to adults with obstructive airways disease in primary and secondary care;Respirology;2023-10-25

5. Long-Term Cost-Effectiveness of Digital Inhaler Adherence Technologies in Difficult-to-Treat Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2023-10